Pregled bibliografske jedinice broj: 254836
Factor V Leiden and prothrombin polymorphism are not risk factor for stroke in elderly
Factor V Leiden and prothrombin polymorphism are not risk factor for stroke in elderly // Clinical Chemistry and Laboratory Medicine / Siest, Gerard (ur.).
Berlin: Walter de Gruyter, 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 254836 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Factor V Leiden and prothrombin polymorphism are not risk factor for stroke in elderly
Autori
Nikolac, Nora ; Šimundić, Ana-Maria ; Štefanović, Mario ; Topić, Elizabeta
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ Siest, Gerard - Berlin : Walter de Gruyter, 2006
Skup
Third "Biologie Prospective" Santorini Conference 2006: "From Human Genetic variations to prediction of risks and responses to drugs and to the environment"
Mjesto i datum
Santorini, Grčka, Santorini, Grčka
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
stroke; factor II; factor V Leiden; polymorphism
Sažetak
Conventional stoke risk factors are age, gender, hypertension, smoking and diabetes mellitus, while it is still undetermined whether genetic polymorphisms in coagulation genes can be considered as risk factors. We hypothesize that genetic risk factors are associated with stroke in elderly. Aim of this study was to evaluate association of factor V Leiden and factor II G20210A polymorphisms vs. conventional risk factors in development of stroke. In a retrospective case-control study, we evaluated 63 patients and 61 controls. Stroke in patients was diagnosed by color imaging techniques. Control individuals were age and sex matched with cases and free of past and present CVI events. Information about conventional risk factors was collected from the medical history and interview. Multiple logistic regression analysis was used to identify significant predictors of stroke. Demographic and other characteristic of the patient and control group were as follows: age 70± ; 9 vs. 71± ; 7 (P = 0, 834) ; proportion of female patients 29/63 vs. 39/61 (P = 0, 067) ; hypertension 54/63 vs. 37/61 (P = 0, 003) ; smoking 8/63 vs. 5/61 (P = 0, 539) ; diabetes mellitus 14/63 vs. 6/61 (P = 0, 116) ; factor II heterozygotes 3/63 vs. 3/61 (P = 0, 680) ; factor V Leiden heterozygotes 3/63 vs. 3/61 (P = 0, 680). Significant predictors of stroke were hypertension (p=0, 001 ; OR=4, 518, 95% CI=1, 817-11, 231) and male gender (P=0, 020 ; OR=2, 502 95% CI= 1, 154 - 5, 427). Whereas all other variables, including factor II and factor V polymorphisms were of no significance. After age adjustment, these variables remained significant: hypertension (p=0.001 ; OR=4, 771 95% CI=1, 884-12, 081) and male gender (P=0, 017 ; OR= 2, 593, 95% CI=1, 183 - 5, 682). Our study showed that male gender and hypertension, but not hereditary thrombophilia are associated with stroke in elderly.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0134019
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Ana-Maria Šimundić
(autor)
Nora Nikolac
(autor)
Mario Štefanović
(autor)
Elizabeta Topić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE